Health Care Archives - Page 24 of 478

2 minute read

MacroGenics Shares Tumble After Reporting Adverse Events, Multiple Deaths In Cancer Drug Trial

May 10, 10:46 AM

Latest interim data from TAMARACK Phase 2 study by MacroGenics unveils insights into vobramitamab duocarmazine targeting B7-H3 in metastatic prostate cancer. Despite responses, notable safety concerns reported.

MGNX

1 minute read

What’s Going On With Medical Therapeutic Firm Aethlon Medical On Friday?

By Vandana Singh

May 10, 10:46 AM

Aethlon Medical unveils results in removing extracellular vesicles (EVs) from plasma. Preclinical evidence supports upcoming phase 1 trials for solid tumor patients undergoing anti-PD-1 monotherapy.

AEMD

2 minute read

FDA Delays ‘Important’ Moderna Vaccine Review: William Blair Says 2025 Growth, ‘2026 Breakeven Story’ Depends On It

By Vandana Singh

May 10, 9:27 AM

FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

GSK

2 minute read

A $1.8 Trillion Market Is Poised To Explode As Personal Health Spending Catches Fire

By Aaron Bry

May 10, 8:48 AM

McKinsey predicts continued growth in the $2 trillion wellness industry, with consumer preferences shifting to clinical effectiveness over clean ingredients.

AAPL

2 minute read

Some Breather For Novavax’s COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern

By Vandana Singh

May 10, 8:06 AM

Novavax strikes co-exclusive licensing deal with Sanofi (SNY) for COVID-19 and flu-COVID-19 vaccines. Terms include upfront payment of $500M, milestone opportunities, and revenue guidance update.

NVAX

2 minute read

Apple’s Vision Pro Headset Becomes Surgeons’ Tool Of Choice For ‘Keyhole’ Surgeries

By Ananya Gairola

May 10, 3:43 AM

Apple Vision Pro mixed-reality headset is gaining popularity among surgeons in India, facilitating over 30 laparoscopic surgeries with enhanced precision and real-time data access.

AAPL

2 minute read

Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know

By Adam Eckert

May 9, 5:25 PM

Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share, which beat estimates for a loss of 42 cents per share.

NVDA

2 minute read

Analysts’ Varied Perspectives On CytomX’s CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

By Vandana Singh

May 9, 2:59 PM

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially in pancreatic cancer, with stable disease maintained.

CTMX

1 minute read

Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024

By Vandana Singh

May 9, 2:24 PM

GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook.

GDRX

2 minute read

Weak Sales From Lipitor, Norvasc Hurt Viatris’ Q1 Earnings, Lowers Annual Forecast

By Vandana Singh

May 9, 2:23 PM

Viatris reports Q1 EPS in line with consensus at $0.67, with sales slightly missing expectations at $3.66 billion. Strong growth in Emerging Markets and Europe offset by challenges in North America. Guidance adjusted slightly downward for 2024.

VTRS